Eir Accelerator has selected 15 women’s health startups across six countries for its inaugural cohort, from 335 applicants spanning 58 countries.
The eight month program will bring founders to Finland to advance their innovations toward clinical validation, partnerships, and investments. Participants will work with hospitals, biobanks, research institutions, and health-data infrastructure.
Eir has partnered with FinBB, the Finnish Biobank Cooperative, giving participating company’s access to Finland’s public biobanks via a single contract – including data related to maternal and perinatal health, endocrine biology and gynaecological cancers. The accelerator has also partnered with biopharmaceutical company Chiesi Group, medical diagnostics provider SYNLAB, and law firm DLA Piper for additional industry expertise and support.
“These companies chose Finland because they can work with our biobanks, hospitals and research institutions while building relationships with investors and pharmaceutical partners who understand women’s health,” said Anastasiya Markvarde, Head of Eir Accelerator.
The initial cohort spans diagnostics, therapeutics, medical devices, and digital health, including:
- Misala Med, an AI-assisted diagnostics and therapeutics company
- EloCare, a cooling wearable for menopause
- Periwinkle Technologies, an AI point-of-care system for cervical cancer screening
- WomenX Biotech, a pad-based diagnostics platform
- ATB Antivirals, a topical therapy for HPV
- DecipHER Women, a peripartum depression prediction algorithm
- MagCath, a urinary incontinence device
- Optimovo, an infertility biotech company
- Thestra, an AI-assisted biomarker test for tumor assessment
- Yuthera, a period and pelvic pain wearable
- Medara, an AI model for breast cancer risk
- Metri Bio, an endometriosis and uterine disease therapeutics developer
- NEXT Life Sciences, a reproductive health platform company developing a treatment for endometriosis
- Metluma, a women’s telehealth platform
- Huna, an AI-assisted risk test for common cancers
